Pangaea Oncology, S.A. (BME:PANG)
Spain
· Delayed Price · Currency is EUR 1.650
0.00 (0.00%)
Mar 4, 2026, 4:00 PM CET
Pangaea Oncology Market Cap
Pangaea Oncology has a market cap or net worth of €56.69 million as of March 5, 2026. Its market cap has decreased by -2.94% in one year.
Market Cap
56.69M
Enterprise Value
59.37M
Revenue
14.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.65
Market Cap Chart
Since December 29, 2016, Pangaea Oncology's market cap has increased from 30.03M to 56.69M, an increase of 88.78%. That is a compound annual growth rate of 7.16%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.48B |
| Laboratorios Farmaceuticos Rovi | 4.26B |
| Almirall | 2.66B |
| Faes Farma | 1.54B |
| Prim, S.A. | 222.91M |
| Oryzon Genomics | 213.69M |
| Atrys Health | 207.14M |
| Laboratorio Reig Jofre | 201.85M |